- The Arrow GlideWheel™ Advancer, which provides tactile feedback and finer control
- Nitinol Guidewire, which is kink-resistant compared to stainless steel
- Transducer Cover to support guidelines for ultrasound use
- Pre-filled sterile saline syringes, one per catheter lumen
- Extra ChloraPrep®
Skin Prep in each kit (two total)
“The ErgoPack® Complete System is built with the inserter in mind, first and foremost,” said
These new additions enhance the already-considerable power of the market-leading2 ErgoPack® System, which features, at its heart, Teleflex’s Arrowg+ard Blue Plus® CVC. It’s the only full-spectrum antimicrobial CVC that protects against gram-positive, gram-negative bacteria and fungi, the key infectious pathogens responsible for CLABSI.
CLABSI is responsible for as many as 28,000 deaths per year in the US.3
The ErgoPack® Complete System’s unique combination of CVC insertion components, packaged in an ergonomic and efficient top down, left to right configuration, helps central line inserters comply with critical third party independent guidelines for reducing CLABSI, including:
Centers for Disease Control and Prevention (CDC) Category 1A & 1B recommendations4Society for Hospital Epidemiology of America (SHEA) Guidelines 5Infusion Nursing Society (INS) Standards of Practice6Occupational Health and Safety Administration (OSHA) Bloodborne Pathogens Standard7
The ErgoPack® Complete System is available in two different configurations, in a variety of catheter French sizes.
Learn more at http://go.teleflex.com/CompleteConfidence
About
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the
Rx only
Contraindication:
The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.
© 2020
References:
- 1.
Raad , II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology. 1994;15(4 Pt 1): 231-238. - DRG data.
Teleflex . 2020. - https://www.ahrq.gov/topics/central-line-associated-bloodstream-infections-clabsi.html
- O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). 2.
Atlanta, GA :Centers for Disease Control and Prevention ; 2017. - Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology. 2014 July; 35(7): 753-71.
- Gorski L, Hadaway L, Hagle ME, McGoldrick M, et al. Infusion Therapy Standards of Practice.
Journal of Infusion Nursing . 2016; Jan 39(1S). - Occupational Safety & Health Administration Regulations (Standards – 29 CFR). Part 1910.1030: Bloodborne pathogens.
Occupational Safety & Health Administration Web site. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030. Accessed onFebruary 12, 2020 .
Source:
Treasurer and Vice President, Investor Relations
610-948-2836
Source:
2020 GlobeNewswire, Inc., source